Divi’s Laboratories Wraps Up US-FDA Inspection at Visakhapatnam Facility with One Minor Observation July 19, 2024, 1:19 p.m. Divi’s Laboratories informed BSE about the completion of a US-FDA inspection at its Unit-II manufacturing facility in Visakhapatnam, Andhra Pradesh.The inspection was conducted from … Unlock the Full Filing And Lot More Access premium insights and stay ahead of the market with Dzambhala Pro. Learn More